NeuralPort

Japan
Ureshinomachi-shimojuku, Saga, Japan, 659-0091

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Seed / 2023-03-21
Last equity funding
Seed
Investors
1
Lead investors
1
Founders
1

Founders and investors

Founders

Anna Shimafuji

Lead investors

Rohto Pharmaceutical

Investors

Rohto Pharmaceutical